Telemetry Investments, L.L.C. Arbutus Biopharma Corp Transaction History

Telemetry Investments, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$5.0 - $7.35 $225,000 - $330,750	-45,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$4.4 - $6.05 $327,786 - $450,706	-74,497 Reduced 62.34%	45,000 $225,000
Q4 2017 Feb 14, 2018	BUY	$4.45 - $7.7 $42,261 - $73,126	9,497 Added 8.63%	119,497 $603,000
Q3 2017 Nov 14, 2017	BUY	$3.4 - $7.0 $374,000 - $770,000	110,000	110,000 $682,000

138

95.5M

3.44M

377K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $577M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.